Quarter Period Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7718695

Concept 2018-04-01 to
2018-09-30
2017-04-01 to
2017-09-30
Quarter period consolidated statement of income
Statement of income
Net sales
22,950,000,000 JPY
23,066,000,000 JPY
Cost of sales
16,191,000,000 JPY
16,423,000,000 JPY
Gross profit (loss)
6,758,000,000 JPY
6,642,000,000 JPY
Selling, general and administrative expenses
Salaries
1,250,000,000 JPY
1,247,000,000 JPY
Depreciation
250,000,000 JPY
218,000,000 JPY
Selling, general and administrative expenses
6,104,000,000 JPY
6,315,000,000 JPY
Operating profit (loss)
654,000,000 JPY
326,000,000 JPY
Non-operating income
Interest income
10,000,000 JPY
10,000,000 JPY
Dividend income
42,000,000 JPY
39,000,000 JPY
Non-operating income
234,000,000 JPY
262,000,000 JPY
Non-operating expenses
Interest expenses
106,000,000 JPY
108,000,000 JPY
Non-operating expenses
194,000,000 JPY
186,000,000 JPY
Ordinary profit (loss)
695,000,000 JPY
403,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
3,000,000 JPY
JPY
Extraordinary losses
7,000,000 JPY
3,000,000 JPY
Profit (loss) before income taxes
687,000,000 JPY
399,000,000 JPY
Income taxes - current
186,000,000 JPY
79,000,000 JPY
Income taxes - deferred
7,000,000 JPY
54,000,000 JPY
Income taxes
194,000,000 JPY
133,000,000 JPY
Profit (loss)
492,000,000 JPY
265,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.